Press Releases on Clinical Trials

Feb 21 2024 01:00
The rise in the patient population of ascites, the availability of products, and the expected launch of emerging therapies will boost the ascites treatment market in the forecast period (2023–2032).


Feb 21 2024 12:01
GAITHERSBURG, Md., Feb. 21, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine...


Feb 21 2024 10:55
Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trials - What to Expect in 2024 - A Preview of Trials Planned to Initiate and Estimated to Complete" report has...


Feb 21 2024 10:00
Life sciences industry veteran brings strong strategic and operational expertise


Feb 21 2024 09:45
New clinical trial methods enable better and more cost-effective clinical research and organizational success. The electronic transcription of data and the use of smart devices and wearable solutions help directly...


Feb 21 2024 09:31
LOS ANGELES, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq: IMMX), a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today announced its 12-month progress update including shareholder...


Feb 21 2024 09:00
Santhera's Study Reports the Results of the 48-Week Treatment with Vamorolone in Patients with Duchenne Muscular Dystrophy (DMD) in the VISION-DMD Study, Supporting the Long-Term Efficacy and Safety Profile of...


Feb 21 2024 08:52
FORT LAUDERDALE, Fla., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (“the “Company”) (NASDAQ: MOTS), a medical technology company focused on improving endoscopic outcomes and experiences, today announced...


Feb 21 2024 08:30
With a growing burden of ocular disease and demand for less invasive procedures, ocular adhesives and sealants present significant potential to address unmet surgical needs and revolutionize standards of care....


Feb 21 2024 08:30
JUPITER, Fla. and NES-ZIONA, Israel, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global biotechnology company specializing in advanced microbial platforms for...

0/5 (0 Reviews)

Don't miss updates from Health Canada and FDA.

If you are looking for the latest regulatory updates or want the newest regulatory requirements guides, please leave your email and we'll keep you posted.

This website uses cookies to provide necessary site functionality and improve your online experience. By using this website, you agree to the use of cookies as outlined in Quality Smart Solutions's online privacy statement.